MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-33-0303377
Pharmnxt Ekuse Private Limited - healthcare in Thane, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹30.3 Cr
▲ 408% YoY
Net loss · FY 2025
₹2.75 Cr
Net margin -9.1%
EBITDA · FY 2025
-₹2.19 Cr
EBITDA margin -7.2%
Authorised capital
₹3.6 Cr
Registered with MCA
Paid-up capital
₹3.6 Cr
Issued & subscribed
Open charges
₹11.1 Cr
Satisfied ₹3.5 Cr
Company age
5 yrs
Est. 2021
Employees · EPFO
40
Provident fund records
About Pharmnxt Ekuse Private Limited
Data last updated:
Pharmnxt Ekuse Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 23 November 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U29308MH2021PTC372043. Its GSTIN is 27AAMCP4816C1ZF (Maharashtra).
The company has an authorised share capital of ₹3.6 Cr and a paid-up capital of ₹3.6 Cr. It is led by directors including Nandkumar Vasant Thakare and Sachin Satish Joshi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 705 Plot – B, Lodha Supremus Thane, Maharashtra, India – 400607.
As per the financials filed for FY 2025, the company reported a revenue of ₹30.3 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹2.75 Cr (net margin -9.1%) and EBITDA of -₹2.19 Cr (EBITDA margin -7.2%).
The company has about 40 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: PharmXnext. As per MCA filings, the company has open charges of ₹11.1 Cr and satisfied charges of ₹3.5 Cr on record.
Pharmnxt Ekuse Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0303377). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website pharmnxtbiotech.com.
Company details
CIN U29308MH2021PTC372043
Registration Number 372043
Incorporation Date 23 November 2021
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-33-0303377
Recognitions & Rankings of Pharmnxt Ekuse
Contact details
Pharmnxt Ekuse Private Limited's registered office is in Thane, Maharashtra. Its website is pharmnxtbiotech.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address705 Plot – B, Lodha Supremus Thane, Maharashtra, India – 400607
- IndustryHealthcare, Medical & Laboratory Equipment
To see the full contact details of Pharmnxt Ekuse Private Limited, buy the company report.
Comprehensive company report
Pharmnxt Ekuse Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Pharmnxt Ekuse operates one associated brand: PharmXnext. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures single-use storage, mixing, and chromatography solutions for biologics production. | pharmnxtbiotech.com |
Business activity
The main business activity of Pharmnxt Ekuse is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products |
To see the full business activity and turnover split of Pharmnxt Ekuse Private Limited, buy the company report.
Financials of Pharmnxt Ekuse Private Limited
FY 2025 filings availablePharmnxt Ekuse Private Limited reported revenue of ₹30.3 Cr (up 408% YoY) for FY 2025.
Revenue · FY 2025
₹30.3 Cr ▲ 408%
Net loss · FY 2025
₹2.75 Cr margin -9.1%
EBITDA · FY 2025
-₹2.19 Cr margin -7.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 408%
EBITDA CAGR growth
1 year
▼ 585%
3 years · compounded
▼ 261%
Revenue rose 408% in the latest year. EBITDA fell 585% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹2.19 Cr | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹2.75 Cr | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -7.2% | |||
| Net Profit Margin | -9.1% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Pharmnxt Ekuse Private Limited, buy the company report.
Board of directors of Pharmnxt Ekuse Private Limited
Pharmnxt Ekuse has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nandkumar Vasant Thakare Also directs: Pharmnxt Biotech LLP, Novelgy Ipsolutions LLP | Director | 23 Nov 2021 | 4 Years 11 Months | Current |
| Sachin Satish Joshi Also directs: Pharmnxt Biotech LLP | Director | 23 Nov 2021 | 4 Years 11 Months | Current |
| Ankush Kapoor Also directs: Pharmnxt Biotech LLP | Director | 23 Nov 2021 | 4 Years 11 Months | Current |
Auditor
Pharmnxt Ekuse Private Limited is audited by Mahadeokar & Yardi Chartered Accountants for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Mahadeokar & Yardi Chartered Accountants | FY 2024 | 135735W |
Shareholding
The shareholding of Pharmnxt Ekuse Private Limited is on record for 3 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Pharmnxt Ekuse Private Limited, buy the company report.
Charges & borrowings
Open charges
₹11.1 Cr
Satisfied charges
₹3.5 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Dec 2024 | 101027398 | Yes Bank Limited | ₹11.1 Cr | Open | |
| 28 Aug 2023 | 100781626 | Others | ₹3.5 Cr | Satisfied |
To see the full charge records of Pharmnxt Ekuse Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Pharmnxt Ekuse Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Pharmnxt Ekuse Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Pharmnxt Ekuse Private Limited has a workforce of 40 employees on its EPFO records as of Oct 20, 2025, across 1 active EPFO establishment.
Employee count
40
Active EPFO establishments
1
Employee growth
33.33%
GST
Pharmnxt Ekuse has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAMCP4816C1ZF | Maharashtra | Active | 31 Dec 2021 |
To see the full GST registrations and return filing status of Pharmnxt Ekuse Private Limited, buy the company report.
Recent activity
Pharmnxt Ekuse Private Limited has 3 board changes on record since 2021: 3 appointments. The latest: Ankush Kapoor was appointed as Director on 23 Nov 2021.
Charges
A charge with Yes Bank Limited of Rs. 11.10 Cr registered on 27 Dec 2024 with Charge ID 101027398 was modified on 30 Jul 2026.
AGM
Pharmnxt Ekuse Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Pharmnxt Ekuse Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Charges
A charge registered on 28 Aug 2023 via Charge ID 100781626 with Others was fully satisfied on 11 Mar 2025.
Charges
A charge with Yes Bank Limited amounted to Rs. 11.10 Cr with Charge ID 101027398 was registered on 27 Dec 2024.
Charges
A charge with Others amounted to Rs. 3.50 Cr with Charge ID 100781626 was registered on 28 Aug 2023.
Appointed
Ankush Kapoor was appointed as Director.
Appointed
Nandkumar Vasant Thakare was appointed as Director.
Appointed
Sachin Satish Joshi was appointed as Director.
Incorporation
23 Nov 2021
Pharmnxt Ekuse Private Limited was registered on 23 Nov 2021 with Roc Mumbai Ii & aged 4 years 11 months as per MCA records.
Frequently asked questions
Pharmnxt Ekuse is an active private limited company based in Thane, Maharashtra, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 23 November 2021 (5+ years old) and is registered under CIN U29308MH2021PTC372043.
Pharmnxt Ekuse has 3 current directors:
- Nandkumar Vasant Thakare - Director
- Sachin Satish Joshi - Director
- Ankush Kapoor - Director
The latest financial statements of Pharmnxt Ekuse on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Pharmnxt Ekuse is 27AAMCP4816C1ZF, registered in Maharashtra.
The CIN (Corporate Identification Number) of Pharmnxt Ekuse is U29308MH2021PTC372043. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Pharmnxt Ekuse was incorporated on 23 November 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
Ankush Kapoor was appointed as Director on 23 Nov 2021. Nandkumar Vasant Thakare was appointed as Director on 23 Nov 2021. Sachin Satish Joshi was appointed as Director on 23 Nov 2021.
Yes, Pharmnxt Ekuse is registered as a small enterprise under Udyam registration (number: UDYAM-MH-33-0303377).
Pharmnxt Ekuse can be reached through the website pharmnxtbiotech.com. Its registered office is in Thane, Maharashtra, India.
The registered office of Pharmnxt Ekuse is at 705 Plot – B, Lodha Supremus Thane, Maharashtra, India – 400607.